These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Wang X; Li Y; Wang X; Wang R; Hao Y; Ren F; Wang P; Fang B Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674791 [TBL] [Abstract][Full Text] [Related]
5. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1. Zhou L; Zhang M; Wang Y; Dorfman RG; Liu H; Yu T; Chen X; Tang D; Xu L; Yin Y; Pan Y; Zhou Q; Zhou Y; Yu C Inflamm Bowel Dis; 2018 Aug; 24(9):1926-1940. PubMed ID: 29796620 [TBL] [Abstract][Full Text] [Related]
6. Inulin-grown Fagundes RR; Bourgonje AR; Saeed A; Vich Vila A; Plomp N; Blokzijl T; Sadaghian Sadabad M; von Martels JZH; van Leeuwen SS; Weersma RK; Dijkstra G; Harmsen HJM; Faber KN Gut Microbes; 2021; 13(1):1993582. PubMed ID: 34793284 [TBL] [Abstract][Full Text] [Related]
7. Faecalibacterium prausnitzii produces butyrate to decrease c-Myc-related metabolism and Th17 differentiation by inhibiting histone deacetylase 3. Zhang M; Zhou L; Wang Y; Dorfman RG; Tang D; Xu L; Pan Y; Zhou Q; Li Y; Yin Y; Zhao S; Wu J; Yu C Int Immunol; 2019 Jul; 31(8):499-514. PubMed ID: 30809639 [TBL] [Abstract][Full Text] [Related]
8. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G mBio; 2014 Aug; 5(4):. PubMed ID: 25118238 [TBL] [Abstract][Full Text] [Related]
9. Expression of CCR6 and CXCR6 by Gut-Derived CD4 Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781 [TBL] [Abstract][Full Text] [Related]
10. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. Miquel S; Leclerc M; Martin R; Chain F; Lenoir M; Raguideau S; Hudault S; Bridonneau C; Northen T; Bowen B; Bermúdez-Humarán LG; Sokol H; Thomas M; Langella P mBio; 2015 Apr; 6(2):. PubMed ID: 25900655 [TBL] [Abstract][Full Text] [Related]
11. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Quévrain E; Maubert MA; Michon C; Chain F; Marquant R; Tailhades J; Miquel S; Carlier L; Bermúdez-Humarán LG; Pigneur B; Lequin O; Kharrat P; Thomas G; Rainteau D; Aubry C; Breyner N; Afonso C; Lavielle S; Grill JP; Chassaing G; Chatel JM; Trugnan G; Xavier R; Langella P; Sokol H; Seksik P Gut; 2016 Mar; 65(3):415-425. PubMed ID: 26045134 [TBL] [Abstract][Full Text] [Related]
12. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. Wrzosek L; Miquel S; Noordine ML; Bouet S; Joncquel Chevalier-Curt M; Robert V; Philippe C; Bridonneau C; Cherbuy C; Robbe-Masselot C; Langella P; Thomas M BMC Biol; 2013 May; 11():61. PubMed ID: 23692866 [TBL] [Abstract][Full Text] [Related]
13. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Miquel S; Martín R; Lashermes A; Gillet M; Meleine M; Gelot A; Eschalier A; Ardid D; Bermúdez-Humarán LG; Sokol H; Thomas M; Theodorou V; Langella P; Carvalho FA Sci Rep; 2016 Jan; 6():19399. PubMed ID: 26775847 [TBL] [Abstract][Full Text] [Related]
14. Induction effects of Faecalibacterium prausnitzii and its extracellular vesicles on toll-like receptor signaling pathway gene expression and cytokine level in human intestinal epithelial cells. Rabiei N; Ahmadi Badi S; Ettehad Marvasti F; Nejad Sattari T; Vaziri F; Siadat SD Cytokine; 2019 Sep; 121():154718. PubMed ID: 31153056 [TBL] [Abstract][Full Text] [Related]
15. Action and function of Faecalibacterium prausnitzii in health and disease. Ferreira-Halder CV; Faria AVS; Andrade SS Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):643-648. PubMed ID: 29566907 [TBL] [Abstract][Full Text] [Related]
17. Administration of live, but not inactivated, Faecalibacterium prausnitzii has a preventive effect on dextran sodium sulfate‑induced colitis in mice. Kawade Y; Sakai M; Okamori M; Morita M; Mizushima K; Ueda T; Takagi T; Naito Y; Itoh Y; Shimada T Mol Med Rep; 2019 Jul; 20(1):25-32. PubMed ID: 31115531 [TBL] [Abstract][Full Text] [Related]
18. Co-Culture with Kim H; Jeong Y; Kang S; You HJ; Ji GE Microorganisms; 2020 May; 8(5):. PubMed ID: 32466189 [No Abstract] [Full Text] [Related]
19. Alterations in the Abundance and Co-occurrence of Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977 [No Abstract] [Full Text] [Related]
20. Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure. Roychowdhury S; Cadnum J; Glueck B; Obrenovich M; Donskey C; Cresci GAM JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1156-1167. PubMed ID: 29385239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]